KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Capital Expenditures (2016 - 2026)

Synopsys (SNPS) has disclosed Capital Expenditures for 18 consecutive years, with $35.3 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Capital Expenditures fell 13.25% year-over-year to $35.3 million, compared with a TTM value of $164.1 million through Jan 2026, up 407.33%, and an annual FY2025 reading of $169.5 million, up 429.31% over the prior year.
  • Capital Expenditures was $35.3 million for Q1 2026 at Synopsys, up from $34.5 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $55.6 million in Q2 2025 and bottomed at -$100.4 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $25.2 million, with a median of $40.0 million recorded in 2024.
  • The sharpest move saw Capital Expenditures skyrocketed 152.86% in 2023, then tumbled 263.39% in 2024.
  • Year by year, Capital Expenditures stood at -$100.4 million in 2022, then surged by 152.86% to $53.1 million in 2023, then crashed by 263.39% to -$86.8 million in 2024, then surged by 139.82% to $34.5 million in 2025, then grew by 2.24% to $35.3 million in 2026.
  • Business Quant data shows Capital Expenditures for SNPS at $35.3 million in Q1 2026, $34.5 million in Q4 2025, and $38.6 million in Q3 2025.